Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015
Guardado en:
| Formato: | Electrónico Revista |
|---|---|
| Lenguaje: | Inglés |
| Publicado: |
Bernstein Global Wealth Management
|
| Materias: | |
| Acceso en línea: | Available in Business Source Complete. |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
Ejemplares similares
- Celgene Corporation SWOT Analysis
- White Book - Celgene: An Abundance of Revlimid Opportunities in Myeloma, But Maintenance Is the Biggest Driver
- Molecular & Cellular Therapies
- Celldex Therapeutics, Inc. SWOT Analysis
-
How to laugh your way through life : a psychoanalyst's advice /
por: Marcus, Paul
Publicado: (2013)